S&P 500   5,000.83 (-0.21%)
DOW   37,915.40 (+0.37%)
QQQ   420.87 (-0.60%)
AAPL   165.35 (-1.01%)
MSFT   402.51 (-0.44%)
META   491.71 (-2.01%)
GOOGL   154.77 (-0.79%)
AMZN   177.68 (-0.86%)
TSLA   148.64 (-0.86%)
NVDA   838.49 (-0.97%)
AMD   152.15 (-1.89%)
NIO   3.86 (-3.50%)
BABA   68.73 (-0.22%)
T   16.41 (+0.49%)
F   12.16 (+0.83%)
MU   110.00 (-1.72%)
GE   152.44 (-0.33%)
CGC   8.11 (+3.58%)
DIS   112.24 (-0.17%)
AMC   3.04 (+4.11%)
PFE   25.48 (+0.35%)
PYPL   62.12 (+0.03%)
XOM   120.24 (+1.45%)
S&P 500   5,000.83 (-0.21%)
DOW   37,915.40 (+0.37%)
QQQ   420.87 (-0.60%)
AAPL   165.35 (-1.01%)
MSFT   402.51 (-0.44%)
META   491.71 (-2.01%)
GOOGL   154.77 (-0.79%)
AMZN   177.68 (-0.86%)
TSLA   148.64 (-0.86%)
NVDA   838.49 (-0.97%)
AMD   152.15 (-1.89%)
NIO   3.86 (-3.50%)
BABA   68.73 (-0.22%)
T   16.41 (+0.49%)
F   12.16 (+0.83%)
MU   110.00 (-1.72%)
GE   152.44 (-0.33%)
CGC   8.11 (+3.58%)
DIS   112.24 (-0.17%)
AMC   3.04 (+4.11%)
PFE   25.48 (+0.35%)
PYPL   62.12 (+0.03%)
XOM   120.24 (+1.45%)
S&P 500   5,000.83 (-0.21%)
DOW   37,915.40 (+0.37%)
QQQ   420.87 (-0.60%)
AAPL   165.35 (-1.01%)
MSFT   402.51 (-0.44%)
META   491.71 (-2.01%)
GOOGL   154.77 (-0.79%)
AMZN   177.68 (-0.86%)
TSLA   148.64 (-0.86%)
NVDA   838.49 (-0.97%)
AMD   152.15 (-1.89%)
NIO   3.86 (-3.50%)
BABA   68.73 (-0.22%)
T   16.41 (+0.49%)
F   12.16 (+0.83%)
MU   110.00 (-1.72%)
GE   152.44 (-0.33%)
CGC   8.11 (+3.58%)
DIS   112.24 (-0.17%)
AMC   3.04 (+4.11%)
PFE   25.48 (+0.35%)
PYPL   62.12 (+0.03%)
XOM   120.24 (+1.45%)
S&P 500   5,000.83 (-0.21%)
DOW   37,915.40 (+0.37%)
QQQ   420.87 (-0.60%)
AAPL   165.35 (-1.01%)
MSFT   402.51 (-0.44%)
META   491.71 (-2.01%)
GOOGL   154.77 (-0.79%)
AMZN   177.68 (-0.86%)
TSLA   148.64 (-0.86%)
NVDA   838.49 (-0.97%)
AMD   152.15 (-1.89%)
NIO   3.86 (-3.50%)
BABA   68.73 (-0.22%)
T   16.41 (+0.49%)
F   12.16 (+0.83%)
MU   110.00 (-1.72%)
GE   152.44 (-0.33%)
CGC   8.11 (+3.58%)
DIS   112.24 (-0.17%)
AMC   3.04 (+4.11%)
PFE   25.48 (+0.35%)
PYPL   62.12 (+0.03%)
XOM   120.24 (+1.45%)
Free Trial

Aura Biosciences (AURA) News Today

→ Biden’s $374B Giveaway Into This Sector (From DTI) (Ad)
Free AURA Stock Alerts
$7.04
-0.02 (-0.28%)
(As of 10:11 AM ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media
SourceHeadline
MarketBeat logoAura Biosciences, Inc. (NASDAQ:AURA) Short Interest Update
americanbankingnews.com - April 17 at 4:36 AM
marketbeat.com logoAura Biosciences, Inc. (NASDAQ:AURA) Sees Significant Growth in Short Interest
marketbeat.com - April 15 at 2:25 PM
marketbeat.com logoAura Biosciences, Inc. (NASDAQ:AURA) Stake Raised by Regency Capital Management Inc. DE
marketbeat.com - April 3 at 10:15 PM
msn.com logo3 Best Stocks to Buy Now, 3/29/2024, According to Top Analysts
msn.com - March 29 at 9:20 AM
markets.businessinsider.com logoAura Biosciences Inc: A Buy Rating on Strong Pipeline and Financial Health
markets.businessinsider.com - March 29 at 9:20 AM
markets.businessinsider.com logoAnalysts Conflicted on These Healthcare Names: Sanofi (OtherSNYNF), Molina Healthcare (MOH) and Aura Biosciences Inc (AURA)
markets.businessinsider.com - March 28 at 1:19 PM
finance.yahoo.com logoWe're Not Very Worried About Aura Biosciences' (NASDAQ:AURA) Cash Burn Rate
finance.yahoo.com - March 28 at 8:18 AM
investorplace.com logoAURA Stock Earnings: Aura Biosciences Beats EPS for Q4 2023
investorplace.com - March 27 at 3:07 PM
benzinga.com logoRecap: Aura Biosciences Q4 Earnings
benzinga.com - March 27 at 12:15 PM
businesswire.com logoAura Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights
businesswire.com - March 27 at 7:00 AM
msn.com logoNational Assembly Counters Doctors Petition on SHIF
msn.com - March 13 at 7:04 PM
marketbeat.com logoDecheng Capital Management III Cayman LLC Buys 869,790 Shares of Aura Biosciences, Inc. (NASDAQ:AURA)
marketbeat.com - March 13 at 8:45 AM
marketbeat.com logoAdage Capital Partners GP L.L.C. Has $25.79 Million Position in Aura Biosciences, Inc. (NASDAQ:AURA)
marketbeat.com - March 7 at 7:44 AM
businesswire.com logoAura Biosciences to Participate in Upcoming Investor Conferences
businesswire.com - February 26 at 7:00 AM
marketbeat.com logoAura Biosciences (AURA) Scheduled to Post Quarterly Earnings on Monday
marketbeat.com - February 25 at 7:32 AM
benzinga.com logoAura Biosciences Stock (NASDAQ:AURA), Short Interest Report
benzinga.com - February 23 at 7:49 AM
marketbeat.com logoAura Biosciences, Inc. (NASDAQ:AURA) Sees Large Decrease in Short Interest
marketbeat.com - February 16 at 3:52 PM
marketbeat.com logoFY2024 EPS Estimates for Aura Biosciences, Inc. (NASDAQ:AURA) Lowered by Analyst
marketbeat.com - February 8 at 8:14 AM
marketbeat.com logoResearch Analysts Issue Forecasts for Aura Biosciences, Inc.'s Q1 2024 Earnings (NASDAQ:AURA)
marketbeat.com - February 7 at 8:07 AM
marketbeat.com logoInsider Selling: Aura Biosciences, Inc. (NASDAQ:AURA) CFO Sells 6,609 Shares of Stock
marketbeat.com - January 24 at 7:48 PM
finance.yahoo.com logoOwning 48% shares,institutional owners seem interested in Aura Biosciences, Inc. (NASDAQ:AURA),
finance.yahoo.com - January 7 at 12:19 PM
markets.businessinsider.com logoBTIG Reaffirms Their Buy Rating on Aura Biosciences Inc (AURA)
markets.businessinsider.com - January 3 at 7:13 PM
finance.yahoo.com logoWall Street Analysts Think Aura Biosciences, Inc. (AURA) Could Surge 174.29%: Read This Before Placing a Bet
finance.yahoo.com - December 11 at 3:27 PM
benzinga.com logoAura Biosciences Stock (NASDAQ:AURA), Analyst Ratings, Price Targets, Predictions
benzinga.com - December 9 at 3:05 PM
finance.yahoo.com logoAura Biosciences Announces First Patient Dosed in Global Phase 3 CoMpass Trial Evaluating the Safety and Efficacy of Belzupacap Sarotalocan (Bel-sar) for First-Line Treatment of Early-Stage Choroidal Melanoma
finance.yahoo.com - December 7 at 10:09 AM
finance.yahoo.com logoWall Street Analysts Believe Aura Biosciences, Inc. (AURA) Could Rally 200.75%: Here's is How to Trade
finance.yahoo.com - November 23 at 3:46 PM
markets.businessinsider.com logoCorrection: Portfolio Company Aura Biosciences Announces Closing of $99 million Public Offering of Common Stock
markets.businessinsider.com - November 13 at 4:30 PM
finance.yahoo.com logoDavid Johnson Bought 232% More Shares In Aura Biosciences
finance.yahoo.com - November 12 at 9:13 AM
msn.com logoInsider Trading: Aura Biosciences Stock (NASDAQ:AURA) Bought by Insiders to the Tune of $16M
msn.com - November 11 at 8:51 AM
msn.com logoAura Biosciences director David Johnson buys common shares worth ~$1.44M
msn.com - November 10 at 2:54 PM
markets.businessinsider.com logoPortfolio Company Aura Biosciences Announces Closing of $99 million Public Offering of Common Stock
markets.businessinsider.com - November 10 at 9:29 AM
markets.businessinsider.com logoPromising Phase 2 Trial Results and Market Potential Bolster Aura Biosciences’ Buy Rating
markets.businessinsider.com - November 8 at 7:39 PM
msn.com logoWhy Aura Biosciences Stock Hit A New 52-Week Low Today
msn.com - November 7 at 7:29 PM
markets.businessinsider.com logoAura Biosciences Prices Public Offering Of 11 Mln Shares Of At $9.00/shr
markets.businessinsider.com - November 7 at 1:30 AM
marketwatch.com logoAura Biosciences Gets FDA Agreement Regarding Phase 3 Clinical Trial of Bel-Sar
marketwatch.com - November 6 at 3:29 PM
finance.yahoo.com logoAura Biosciences Receives FDA Agreement Under Special Protocol Assessment (SPA) for CoMpass Phase 3 Clinical Trial of Belzupacap Sarotalocan (Bel-sar) in Early-stage Choroidal Melanoma
finance.yahoo.com - November 6 at 3:29 PM
morningstar.com logoAura Biosciences Inc AURA
morningstar.com - November 5 at 12:29 PM
businesswire.com logoAura Biosciences to Present Updated Phase 2 Data Evaluating Suprachoroidal Administration of Belzupacap Sarotalocan (Bel-sar) for the First-Line Treatment of Patients with ...
businesswire.com - November 1 at 12:32 AM
finance.yahoo.com logoAura Biosciences to Present Updated Phase 2 Data Evaluating Suprachoroidal Administration of Belzupacap Sarotalocan (Bel-sar) for the First-Line Treatment of Patients with Early-Stage Choroidal Melanoma at AAO 2023
finance.yahoo.com - October 31 at 7:31 PM
finance.yahoo.com logoAura Biosciences Independent Chairman of the Board Acquires 30% More Stock
finance.yahoo.com - October 8 at 9:42 AM
uk.finance.yahoo.com logoAura Biosciences, Inc. (AURA) stock price, news, quote & history – Yahoo Finance
uk.finance.yahoo.com - October 7 at 8:26 AM
barrons.com logoAura Biosciences Inc.
barrons.com - October 2 at 9:13 PM
finance.yahoo.com logoAura Biosciences Strengthens and Expands Leadership Team with Key Appointments
finance.yahoo.com - October 2 at 9:13 PM
marketbeat.com logoLong Focus Capital Management LLC Purchases Shares of 171,377 Aura Biosciences, Inc. (NASDAQ:AURA)
marketbeat.com - September 13 at 5:54 AM
marketbeat.com logoMartingale Asset Management L P Takes Position in Aura Biosciences, Inc. (NASDAQ:AURA)
marketbeat.com - September 8 at 5:28 AM
fool.com logoAura Biosciences (NASDAQ: AURA)
fool.com - August 27 at 3:42 AM
marketbeat.com logoMirae Asset Global Investments Co. Ltd. Invests $108,000 in Aura Biosciences, Inc. (NASDAQ:AURA)
marketbeat.com - August 23 at 4:24 AM
marketbeat.com logoSG Americas Securities LLC Buys Shares of 11,201 Aura Biosciences, Inc. (NASDAQ:AURA)
marketbeat.com - August 16 at 4:07 AM
marketbeat.com logoAura Biosciences, Inc. to Post Q3 2023 Earnings of ($0.55) Per Share, Leerink Partnrs Forecasts (NASDAQ:AURA)
marketbeat.com - August 14 at 2:46 AM
msn.com logoInnergex Renewable Energy GAAP EPS of C$0.09, revenue of C$251.91M
msn.com - August 9 at 3:18 PM
Get Aura Biosciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for AURA and its competitors with MarketBeat's FREE daily newsletter.

I’m officially sounding the alarm. (Ad)

AI has been the hottest financial story of 2023. And rightly so – AI stocks have beat the broader market by over 62%. But right now, my system is warning me that many AI stocks are riding higher on hype alone.

Just click here to watch my full uncensored interview.

AURA Media Mentions By Week

AURA Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

AURA
News Sentiment
▼
1.28

0.52
▲
Average
Medical
News Sentiment

AURA News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

AURA Articles
This Week
▼
2

1
▲
AURA Articles
Average Week

Get Aura Biosciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for AURA and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

Related Companies:
Headlines Tools:
This page (NASDAQ:AURA) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
Healthcare Takes A Big Step Forward With The Help Of AI
The Bull Report
Biden’s $374B Giveaway Into This Sector
DTI
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
The “Perfect Storm” for Gold
Gold Safe Exchange
Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS
Paradigm Press
The #1 Crypto for 2024
InvestorPlace
He Is Giving Away Bitcoin
Crypto Swap Profits
Your Money is Not Safe
American Alternative